Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga December 31, 2015 at 08:06 AM EST Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares rose 21.21 percent to $1.200 after the company reported that the U.S. FDA has ... Read More >> Related Stocks: Chimerix Inc Perion Network Ltd Pluristem Therapeutc Vodafone Grp Plc ADR